396 related articles for article (PubMed ID: 17674974)
21. Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma.
de Perrot M; McRae K; Anraku M; Karkouti K; Waddell TK; Pierre AF; Darling G; Keshavjee S; Johnston MR
Ann Thorac Surg; 2008 Apr; 85(4):1206-10. PubMed ID: 18355497
[TBL] [Abstract][Full Text] [Related]
22. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.
Sugarbaker DJ; Wolf AS; Chirieac LR; Godleski JJ; Tilleman TR; Jaklitsch MT; Bueno R; Richards WG
Eur J Cardiothorac Surg; 2011 Aug; 40(2):298-303. PubMed ID: 21310625
[TBL] [Abstract][Full Text] [Related]
23. Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.
de Perrot M; Uy K; Anraku M; Tsao MS; Darling G; Waddell TK; Pierre AF; Bezjak A; Keshavjee S; Johnston MR
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):111-6. PubMed ID: 17198794
[TBL] [Abstract][Full Text] [Related]
24. [Extrapleural pneumonectomy for malignant pleural mesothelioma].
Hosokawa Y; Matsuge S; Hayashi K; Kawahara Y; Ishigooka M; Kan T; Yamaawa T; Hatakeyama H; Murakami Y
Kyobu Geka; 2004 Oct; 57(11):1018-22. PubMed ID: 15510814
[TBL] [Abstract][Full Text] [Related]
25. A pilot trial of high-dose-rate intraoperative radiation therapy for malignant pleural mesothelioma.
Rosenzweig KE; Fox JL; Zelefsky MJ; Raben A; Harrison LB; Rusch VW
Brachytherapy; 2005; 4(1):30-3. PubMed ID: 15737904
[TBL] [Abstract][Full Text] [Related]
26. High-dose-rate surface brachytherapy to boost elongated, curvilinear incisional scars after extrapleural pneumonectomy for malignant pleural mesothelioma treated with adjuvant intensity-modulated radiation therapy.
Doyle LA; Showalter TN; Werner-Wasik M; Weksler B; Xiao Y; Yu Y; Macrone A; Liu H; Harrison A
Brachytherapy; 2010; 9(1):86-90. PubMed ID: 19846346
[TBL] [Abstract][Full Text] [Related]
27. Prognostic features of long-term survivors after surgical management of malignant pleural mesothelioma.
Yan TD; Boyer M; Tin MM; Sim J; Kennedy C; McLean J; Bannon PG; McCaughan BC
Ann Thorac Surg; 2009 May; 87(5):1552-6. PubMed ID: 19379903
[TBL] [Abstract][Full Text] [Related]
28. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
Flores RM; Pass HI; Seshan VE; Dycoco J; Zakowski M; Carbone M; Bains MS; Rusch VW
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):620-6, 626.e1-3. PubMed ID: 18329481
[TBL] [Abstract][Full Text] [Related]
29. Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma.
Martin-Ucar AE; Nakas A; Edwards JG; Waller DA
Eur J Cardiothorac Surg; 2007 May; 31(5):765-70; discussion 770-1. PubMed ID: 17337201
[TBL] [Abstract][Full Text] [Related]
30. Hemithoracic radiotherapy after extrapleural pneumonectomy for malignant pleural mesothelioma: a dosimetric comparison of two well-described techniques.
Hill-Kayser CE; Avery S; Mesina CF; James P; Friedberg JS; Cengel K; Lin LL; Hahn SM; Rengan R
J Thorac Oncol; 2009 Nov; 4(11):1431-7. PubMed ID: 19745767
[TBL] [Abstract][Full Text] [Related]
31. A feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation for malignant pleural mesothelioma.
Yamanaka T; Tanaka F; Hasegawa S; Okada M; Soejima T; Kamikonya N; Fukuoka K; Nakano T
Jpn J Clin Oncol; 2009 Mar; 39(3):186-8. PubMed ID: 19131427
[TBL] [Abstract][Full Text] [Related]
32. Hemithoracic intensity modulated radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis.
Chance WW; Rice DC; Allen PK; Tsao AS; Fontanilla HP; Liao Z; Chang JY; Tang C; Pan HY; Welsh JW; Mehran RJ; Gomez DR
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):149-56. PubMed ID: 25442335
[TBL] [Abstract][Full Text] [Related]
33. Helical tomotherapy for resected malignant pleural mesothelioma: dosimetric evaluation and toxicity.
Giraud P; Sylvestre A; Zefkili S; Lisbona A; Bonnette P; Le Pimpec Barthes F; Paris E; Perigaud C; Savignoni A; Mahé MA
Radiother Oncol; 2011 Nov; 101(2):303-6. PubMed ID: 21864923
[TBL] [Abstract][Full Text] [Related]
34. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
Neragi-Miandoab S; Richards WG; Sugarbaker DJ
Int J Surg; 2008 Aug; 6(4):293-7. PubMed ID: 18585112
[TBL] [Abstract][Full Text] [Related]
35. [Extrapleural pneumonectomy of malignant pleural mesothelioma].
Yoon HE; Nonaka K; Fukuhara K; Ueshima H; Sugiura T; Kaneda H; Shimamoto S; Imakita M; Iwase K
Kyobu Geka; 2004 Oct; 57(11):1011-5. PubMed ID: 15510813
[TBL] [Abstract][Full Text] [Related]
36. Staging of patients after extrapleural pneumonectomy for malignant pleural mesothelioma--institutional review and current update.
Cao C; Krog Andvik SK; Yan TD; Kennedy C; Bannon PG; McCaughan BC
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):754-7. PubMed ID: 21303872
[TBL] [Abstract][Full Text] [Related]
37. Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.
Aigner C; Hoda MA; Lang G; Taghavi S; Marta G; Klepetko W
Eur J Cardiothorac Surg; 2008 Jul; 34(1):204-7. PubMed ID: 18407510
[TBL] [Abstract][Full Text] [Related]
38. Long-term survival after lung-sparing total pleurectomy for locally advanced (International Mesothelioma Interest Group Stage T3-T4) non-sarcomatoid malignant pleural mesothelioma.
Nakas A; von Meyenfeldt E; Lau K; Muller S; Waller D
Eur J Cardiothorac Surg; 2012 May; 41(5):1031-6. PubMed ID: 22219469
[TBL] [Abstract][Full Text] [Related]
39. Considerations for post-operative radiotherapy to the hemithorax following extrapleural pneumonectomy in malignant pleural mesothelioma.
Senan S; van de Pol M
Lung Cancer; 2004 Aug; 45 Suppl 1():S93-6. PubMed ID: 15261442
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
